For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with escalating treatment with dulaglutide, according to a study published […]
Researchers at the University of Queensland have found that improving the function of the gut microbiome may delay the onset of type 1 diabetes (T1D). The study was published in Nature Communications.This article was originally […]
New research led by Western Sydney University finds limited evidence on the association between health literacy and medication adherence among ethnic minority adults living with type 2 diabetes.This article was originally published on MedicalXpress.com
A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute for Diabetes Technology, and another colleague with the University of Munich, both in Germany, […]
Relatively inexpensive and accessible self-management interventions to help people manage type 2 diabetes have been found to significantly reduce the blood sugar marker used to diagnose and manage the disease.This article was originally published on […]
Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, UVA Health diabetes experts note in a new paper highlighting a growing array of treatment […]
Researchers from the School of Public Health, LKS Faculty of Medicine of the University of Hong Kong (HKUMed) conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing […]
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and type 2 diabetes in the first-of-its kind trial to evaluate the use of a […]
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.This article was originally published on […]
Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca